Trade Mark Journal No.2024/020 17 May 2024

UK00004045916 30 April 2024 (5,42)

CLOUDBREAK

International priority date claimed: 22 December 2023 (United States of America) (98327552)

Class 5: Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment or prevention of infectious diseases.
Class 42: Pharmaceutical research and development; research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform.

Cidara Therapeutics, Inc.

Representative: Mishcon de Reya LLP